Metraipolis › archive › dc_af1f4ee984ee

PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD — Europe PMC PMID:41002439

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41002439
DOI
10.3390/cells14181474
License (as archived)
solo-consultazione
Archived
2026-11-09T20:09:45.581Z
SHA-256 of the archived text
fb753ef6cb6b9854d67e5c17a392399df0b4aa1ec90681e269e39155f79ad5e7
Stable URL of this page
https://metraipolis.com/documento/dc_af1f4ee984ee

How to cite

PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD — Europe PMC PMID:41002439 — Europe PMC (en), https://europepmc.org/article/MED/41002439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_af1f4ee984ee (Metraipolis archive dc_af1f4ee984ee, sha256 fb753ef6cb6b9854d67e5c17a392399df0b4aa1ec90681e269e39155f79ad5e7)
BibTeX
@misc{dcaf1f4ee984ee,
  title = {PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD — Europe PMC PMID:41002439},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41002439},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_af1f4ee984ee; sha256 fb753ef6cb6b9854d67e5c17a392399df0b4aa1ec90681e269e39155f79ad5e7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41002439. Agents can read the archived copy with the MCP tool read_document.